Metformin’s Potential Role in PCO - Top-Institutions - MDSpire

Metformin’s Potential Role in PCO

Common diabetes therapy reaches intraocular lens tissue and may help limit posterior capsule opacification, says newly published data

  • By

  • Conexiant News Staff

  • March 5, 2026

  • 3 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts Eye and Ear Infirmary
    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Translational Medicine
    • Pharmacology

  • #2

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Clinical Research
    • Pharmacology

  • #3

    University of California, San Francisco (UCSF) School of Medicine
    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    Key Differentiators

    • Ophthalmology
    • Biomedical Research
    • Pharmacology

  • #4

    Vienna General Hospital (Medizinische Universität Wien)
    Vienna General Hospital (Medizinische Universität Wien)

    Vienna, Vienna

    Key Differentiators

    • Ophthalmology
    • Clinical Pharmacology
    • Translational Research

  • #5

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Clinical Trials
    • Molecular Biology

Original Source(s)

Metformin’s Potential Role in PCO

  • by Conexiant News Staff

  • March 5, 2026

Related Content

From Babylon to Berlin

Iraqi-born ophthalmologist Hasan Chichan reflects on bridging the divide between modern retina care and humanitarian medicine

Bag-in-the-lens technique

Investigational OCTA Devices Show Promise in Diabetic Disease Assessment

At Retina World Congress, Patricio G. Schlottmann, MD, discussed investigational widefield OCTA platforms made by Chinese company TowardPi Medical.